Inactive Instrument

Calendar Xeris Biopharma Holdings, Inc. Nasdaq

Equities

XERS

US98422L1070

Chart calendar Xeris Biopharma Holdings, Inc.

cc9f.QwiM62_Sk99IHpe7pvuI4EiqrE9omUyhQ1BpeASvjVM.L2v20w3m45UsWPPsyaztrTD1xxc8qhjLEmIfKTHK4SoiMNTcAZbj7S5spw~10a4bbe42a25e46bec93b509933a36fb

Upcoming events on Xeris Biopharma Holdings, Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
07/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Xeris Biopharma Holdings, Inc.

09/04/2024 08:30 pm Needham Healthcare Conference
11/03/2024 08:50 pm Leerink Partners Global Biopharma Conference
06/03/2024 07:00 pm Q4 2023 Earnings Call
06/03/2024 05:32 pm Q4 2023 Earnings Release
13/02/2024 08:30 pm Oppenheimer Healthcare Life Sciences Conference
12/01/2024 01:30 am JPMorgan Healthcare Conference
09/11/2023 07:00 pm Q3 2023 Earnings Call
09/11/2023 05:30 pm Q3 2023 Earnings Release
28/09/2023 10:10 pm Cantor Global Healthcare Conference
11/09/2023 07:00 pm H.C. Wainwright Global Investment Conference
08/08/2023 06:00 pm Q2 2023 Earnings Call
08/08/2023 04:30 pm Q2 2023 Earnings Release
08/06/2023 08:00 pm Jefferies Healthcare Conference - Fireside Chat
07/06/2023 06:30 pm Annual General Meeting
09/05/2023 06:00 pm Q1 2023 Earnings Call
09/05/2023 04:30 pm Q1 2023 Earnings Release
08/03/2023 07:00 pm Q4 2022 Earnings Call
08/03/2023 05:30 pm Q4 2022 Earnings Release
15/02/2023 09:10 pm SVB Securities Global Biopharma Conference
13/01/2023 01:30 am JP Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2,72
1,49
82.42%
20,4
22,2
-8.04%
49,6
47,5
4.47%
110
108
2.04%
164
163
0.79%

184

EBITDA
Million USD
Released
Forecast
Spread
-121
-112
-8.79%
-82,1
-76,3
-7.57%
0,00
0,00
-
-69,7
-61,6
-13.22%
-30,9
-19,5
-58.21%

-7,25

EBIT
Million USD
Released
Forecast
Spread
-122
-119
-2.75%
-83,5
-80,5
-3.74%
-115
-91,8
-25.47%
-81,9
-81,6
-0.44%
-44,0
-41,3
-6.69%

-29,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-126
-124
-1.69%
-91,3
-88,4
-3.17%
-123
-99,6
-23.21%
-96,1
-99,8
3.7%
-63,5
-61,2
-3.78%

-53,2

Net income
Million USD
Released
Forecast
Spread
-126
-124
-1.33%
-91,1
-88,4
-3.09%
-123
-98,2
-25.03%
-94,7
-102
7.07%
-62,3
-60,1
-3.57%

-55,9

EPS
USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-1,55
-1,32
-17.2%
-0,70
-0,75
7.08%
-0,45
-0,43
-3.69%

-0,39

Announcement Date11/03/2009/03/2110/03/2208/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
21,4
19,0
12.94%
22,1
23,4
-5.64%
25,3
25,5
-0.88%
29,7
29,1
2.07%
33,1
31,0
6.79%
33,2
30,8
7.9%
38,0
34,8
9.1%
48,3
41,1
17.61%
44,4
43,6
1.93%

41,8


45,1


48,1


49,4


51,8

EBITDA
Million USD
Released
Forecast
Spread












-12,1
-13,6
10.88%













-6,44


-3,46


-0,10


2,76




EBIT
Million USD
Released
Forecast
Spread
-48,3
-25,2
-91.59%
-29,1
-28,9
-0.7%
-18,9
-27,9
32.32%
-18,8
-17,3
-8.26%
-15,2
-17,5
13.39%
-13,3
-19,1
30.53%
-16,0
-14,2
-12.88%
-4,91
-10,4
52.54%
-9,84
-9,51
-3.49%

-10,7


-8,88


-5,36


-4,36


-2,90

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-50,8
-28,1
-81.01%
-34,1
-31,2
-9.24%
-26,5
-30,2
12.16%
-22,2
-21,9
-1.02%
-13,3
-21,0
36.91%
-16,8
-25,0
32.68%
-20,5
-20,5
-0.28%
-12,5
-14,9
16.02%
-13,6
-14,6
6.95%

-16,6


-14,9


-11,4


-10,4


-8,00

Net income
Million USD
Released
Forecast
Spread
-50,8
-26,5
-91.34%
-33,7
-32,7
-3.02%
-26,2
-30,4
14%
-21,8
-23,8
8.36%
-12,9
-22,4
42.15%
-16,8
-23,6
28.53%
-19,8
-17,5
-13.26%
-12,2
-15,5
21.55%
-13,4
-13,7
2.32%

-16,6


-15,0


-12,5


-11,8


-8,00

EPS
USD
Released
Forecast
Spread
-0,44
-0,26
-70.87%
-0,25
-0,25
0%
-0,19
-0,23
15.56%
-0,16
-0,17
4%
-0,10
-0,16
37.5%
-0,12
-0,17
29.41%
-0,14
-0,13
-9.8%
-0,09
-0,12
22.41%
-0,10
-0,10
-2.04%

-0,12


-0,11


-0,09


-0,08


-0,06

Announcement Date10/03/2211/05/2210/08/2209/11/2208/03/2309/05/2308/08/2309/11/2306/03/24-----
  1. Stock Market
  2. Equities
  3. XERS Stock
  4. XERS Stock
  5. Calendar Xeris Biopharma Holdings, Inc.